Sponsored by:

ACC.10/i2 Summit

Atlanta, Georgia; March 13-16

Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Tuesday March 16 2010

  • Effect of Genotyping Warfarin Patients on Outcomes: Results from The National Community-based Medco-Mayo Warfarin Effectiveness Study (MM-WES) – Robert S. Epstein

  • Diuretic Strategies In Acute Decompensated Heart Failure: the Diuretic Optimization Strategies Evaluation Study (DOSE) – Gary Michael Felker

  • Effect of the Direct Renin Inhibitor Aliskiren on Left Ventricular Remodeling Following Myocardial Infarction with Left Ventricular Dysfunction (ASPIRE) – Scott D. Solomon

  • Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis – Francois Schiele

  • Influence of Reduction of Left Ventricular Volume on Outcome After Coronary Artery Bypass Grafting With or Without Surgical Ventricular Reconstruction (STICH) – Robert E. Michler

  • Randomized Comparison of AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting to Direct Stenting Alone in Patients with Acute Myocardial Infarction (JETSTENT) – David Antoniucci

  • Long-term Outcome after Drug-Eluting versus Bare-Metal Stent Implantation in Patients with ST-Elevation Myocardial Infarction: Three-year follow-up of DEDICATION – Peter Clemmensen

  • Five-Year Follow-up After Primary Percutaneous Coronary Intervention With A Paclitaxel-eluting Stent Versus A Bare-metal Stent In Acute ST-segment Elevation Myocardial Infarction (PASSION) – Maarten Vink

  • Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery (PLATO) – Claes Held

  • A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study – Steven Goldman

Monday March 15 2010

  • Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation (STOP-AF) – Douglas L. Packer

  • Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison Between Lenient Versus Strict Rate Control in Patients With and Without Heart Failure (RACE II) – Isabelle C. Van Gelder

  • The Impact of Remote Monitoring with Automatic Clinician Notifications on the clinical care of ICD and CRT-D Patients (CONNECT) – George H. Crossley, III

  • A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation (EXPLORE-Xa) – Michael D. Ezekowitz

  • Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) – Douglas L. Packer

  • Randomized All-comer Comparison Of Zotarolimus-eluting And Sirolimus-eluting Coronary Stents: 18-month Follow-up In The SORT OUT III Trial – Michael Maeng

  • Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents – Two-year Clinical and Angiographic Outcomes (ISAR-TEST2) – Robert A. Byrne

  • Comparison of a Novel Platinum-Chromium, Thin-Strut TAXUS Element Stent Versus the TAXUS Express Stent in de novo Coronary Stenoses (PERSEUS) – Dean J. Kereiakes

  • Efficacy of Cilostazol on Ischemic Vascular Complications after Drug-eluting Stent Implantation for Coronary Heart Disease (CILON-T) – Hyo-Soo Kim

  • Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation (DES-LATE) – Seung-Jung Park

Sunday March 14 2010

  • Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study – Henry Ginsberg

  • Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Blood Pressure Trial – William C. Cushman

  • Rethinking Lower BP Goals For Diabetics With Documented Coronary Artery Disease (INVEST) – Rhonda M. Cooper-Dehoff

  • The Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research Trial (NAVIGATOR) – Robert M. Califf

  • Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial – Ted Feldman

  • Long-Term Safety and Efficacy of Stenting versus Coronary-Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results from the MAINCOMPARE Registry – Seung-Jung Park

  • Preventive Strategies of REnal Insufficiency in Patients with Diabetes Undergoing InterVENTion or Arteriography (PREVENT) – Won-Jang Kim

  • Long-term Outcome Of A Routine Versus Selective Invasive Strategy In Patients With Non ST Elevation Acute Coronary Syndrome (FIR Trial Collaboration) – Keith A. A. Fox

  • The Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA): Blood Pressure Variability and Cardiovascular Outcomes – Peter Sever

  • The Cost of Clopidogrel Use in Atrial Fibrillation: A Health Economic Analysis of ACTIVE-A – Andre Lamy